Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...
December 28, 2025 • At the end of every year, many of us resolve to make small changes in our lives. But what would it take to make a radical change–and can it still be done if you’ve reached ...
The key to light, fluffy celeriac mash is to include some floury potatoes (such as Maris Piper or King Edward), this ensures you'll get smooth creamy mash, just as it ought to be. Put the potatoes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback